Sensus Healthcare to Report 2024 Fourth Quarter and Full Year Financial Results and Hold Business Update Conference Call on Wednesday, February 5, 2025
23 January 2025 - 12:00AM
Business Wire
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device
company specializing in highly effective, non-invasive,
minimally-invasive and cost-effective treatments for oncological
and non-oncological skin conditions, announces the company will
report financial results for the 2024 fourth quarter and full year
on Wednesday, February 5, 2025. Management will hold a conference
call beginning at 4:30 p.m. Eastern time to review the results,
provide a business update and answer questions.
Participants are encouraged to pre-register for the conference
call using this link to receive a unique dial-in number to bypass
the live operator. Participants may pre-register at any time,
including up to and after the call start time. Those unable to
pre-register can access the conference call by dialing 844-481-2811
(U.S. and Canada Toll Free) or 412-317-0676 (International). Please
ask the operator to be connected to the Sensus Healthcare
conference call.
The call will be webcast live and can be accessed at this link,
which is also in the Investor Relations section of the Company’s
website at www.sensushealthcare.com.
Following the conclusion of the conference call, a telephone
replay will be available until March 5th by dialing 877-344-7529
(U.S. Toll Free), 855-669-9658 (Canada Toll Free) or 412-317-0088
(International). At the system prompt, enter the replay code
5636219. An archived webcast will be available in the Investor
Relations section of the Company’s website for a period of
time.
About Sensus Healthcare
Sensus Healthcare, Inc. is a global pioneer in the development
and delivery of non-invasive treatments for skin cancer and
keloids. Leveraging its cutting-edge superficial radiotherapy (SRT
and IG-SRT) technology, the company provides healthcare providers
with a highly effective, patient-centric treatment platform. With a
dedication to driving innovation in radiation oncology, Sensus
Healthcare offers solutions that are safe, precise, and adaptable
to a variety of clinical settings. For more information, please
visit www.sensushealthcare.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20250122504110/en/
Alliance Advisors IR Tirth T. Patel
tpatel@allianceadvisors.com 212-201-6614
Sensus Healthcare (NASDAQ:SRTS)
Historical Stock Chart
From Jan 2025 to Feb 2025
Sensus Healthcare (NASDAQ:SRTS)
Historical Stock Chart
From Feb 2024 to Feb 2025